HORIBA

HORIBA develops and markets advanced scientific instruments for life science research, biopharma manufacturing analytics, clinical diagnostics (in vitro), environmental monitoring, semiconductor analysis and more. Its technologies support R&D through to manufacturing QC in pharma/biotech but it does not have its own drug pipeline. The company’s medical segment produces hematology analyzers and reagents used globally in clinical labs.

In biopharma/life sciences specifically: "HORIBA will develop and deliver innovative analytical and automation solutions... contributing to breakthroughs in drug development and manufacturing..."

In diagnostics: "The HORIBA Medical segment designs and manufactures medical instruments... for the in vitro diagnostics industry."

No direct clinical results as it does not run trials on therapeutics.